FLEXION THERAPEUTICS INC's ticker is FLXN and the CUSIP is 33938J106. A total of 137 filers reported holding FLEXION THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 2.16 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $241,000 | +190.4% | 39,608 | +290.9% | 0.00% | – |
| Q2 2021 | $83,000 | -95.2% | 10,132 | -94.7% | 0.00% | -100.0% |
| Q1 2021 | $1,723,000 | +153.8% | 192,530 | +227.7% | 0.00% | – |
| Q4 2020 | $679,000 | +21.7% | 58,751 | +9.5% | 0.00% | – |
| Q3 2020 | $558,000 | -9.0% | 53,661 | +15.2% | 0.00% | – |
| Q2 2020 | $613,000 | +22.8% | 46,600 | +93.6% | 0.00% | – |
| Q4 2019 | $499,000 | +93.4% | 24,068 | +27.7% | 0.00% | – |
| Q3 2019 | $258,000 | +100.0% | 18,840 | +79.3% | 0.00% | – |
| Q2 2019 | $129,000 | -44.6% | 10,508 | +1.0% | 0.00% | -100.0% |
| Q1 2018 | $233,000 | -33.8% | 10,400 | -26.1% | 0.00% | 0.0% |
| Q4 2017 | $352,000 | -27.3% | 14,076 | -56.8% | 0.00% | -66.7% |
| Q3 2015 | $484,000 | – | 32,593 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Clearline Capital LP | 391,076 | $7,317,000 | 4.33% |
| Rubric Capital Management LP | 2,125,000 | $39,759,000 | 4.20% |
| Gagnon Advisors, LLC | 225,062 | $4,211,000 | 2.52% |
| GAGNON SECURITIES LLC | 450,655 | $8,432,000 | 1.94% |
| MILLER VALUE PARTNERS, LLC | 2,881,200 | $53,907,000 | 1.74% |
| PECONIC PARTNERS LLC | 222,965 | $4,172,000 | 1.05% |
| ARDSLEY ADVISORY PARTNERS LP | 415,000 | $7,765,000 | 1.05% |
| Rhenman & Partners Asset Management AB | 532,812 | $9,969,000 | 1.00% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 574,483 | $10,749,000 | 0.75% |
| Kerrisdale Advisers, LLC | 37,145 | $695,000 | 0.68% |